📖 Approx. 3 minutes ／ Updated 2026.06.28
In this article, a medical industry M&A advisor will explain from a practical perspective what issues arise when converting to a Designated Medical Corporation in business succession and medical M&A for OB/GYN practices. We will provide specific countermeasures based on valuation differences due to the presence or absence of delivery services, specialization in gynecology, tax incentives, and public benefit requirements.
1. Industry Background for OB/GYN Designated Medical Corporation Conversion
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including OB/GYN, has become increasingly severe in recent years due to complex factors such as revisions to medical fees, soaring personnel costs, and the burden of capital investment. Particularly from the perspective of valuation differences based on the presence or absence of delivery services and specialization in gynecology, interest in third-party succession M&A is growing.
At the same time, conversion to a Designated Medical Corporation becomes a crucial point in medical M&A practice. By appropriately designing tax incentives and public benefit requirements, a succession that benefits both the transferor and transferee can be achieved.
2. Key Practical Points
- Preparation: Organize OB/GYN-specific operational workflows, patient base, and equipment status, and clarify transfer conditions.
- Business Valuation: Calculate an appropriate transfer price range based on the medical specialty’s characteristics. In OB/GYN, valuation differences based on the presence or absence of delivery services and specialization in gynecology are key factors.
- Design of Designated Medical Corporation Conversion: Select the optimal scheme based on tax incentives and public benefit requirements. Verification from tax, legal, and labor perspectives is also necessary.
- Buyer Search and Matching: Select potential transferees suitable for the medical specialty from a nationwide network. Carefully coordinate desired conditions.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also confirm OB/GYN-specific licenses, permits, and facility standards.
- Final Agreement and Closing: Conclude the final agreement, including representations, warranties, and indemnity clauses. Proceed with license/permit transfer and staff notification in parallel.
3. Specific Considerations for OB/GYN
In medical institution M&A for OB/GYN, valuation differences based on the presence or absence of delivery services and specialization in gynecology hold the key to successful succession. Numerous individual issues exist depending on the medical specialty’s characteristics, such as the continuity of the patient base, maintaining employment for staff (doctors, nurses, paramedical staff), equipment status and renewal plans, and maintaining/acquiring facility standards.
Furthermore, strategic planning based on market characteristics unique to OB/GYN, such as the composition of insured and self-pay medical services, the status of regional medical collaboration, and relationships with nearby competing medical institutions, is crucial. Leveraging our track record in OB/GYN succession support, we provide practical assistance from an industry-specific perspective.
4. Practical Details of Designated Medical Corporation Conversion
Converting to a Designated Medical Corporation is an area requiring specialized consideration in medical M&A. Designing based on tax incentives and public benefit requirements is key to success.
- Confirmation of Related Laws and Practical Standards: Preparation based on the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and formulation of countermeasures.
- Consensus Building Between Parties: Designing mutually agreeable conditions for both the transferor and transferee.
- Proper Documentation: Clear specification in the basic agreement and final contract.
Frequently Asked Questions
Q. What documents are required for consultation?
A. It would be helpful if you could prepare in advance the financial statements for the last three fiscal years, patient volume trends, staff composition, equipment list, and lease agreements (if applicable). We will receive them after an NDA is signed.
Q. What is the market price range for OB/GYN transfers?
A. For OB/GYN, valuation differences based on the presence or absence of delivery services and specialization in gynecology are key valuation factors. For clinics without beds, the guideline is 0.5 to 1.5 times annual revenue, and for hospitals with beds, it’s 3 to 7 times EBITDA. We will provide details in a free preliminary assessment.
Q. What are the precautions when proceeding with Designated Medical Corporation conversion?
A. Prior design based on tax incentives and public benefit requirements is essential. Seamless practical execution through expert collaboration is key to success.
Q. Will staff and patients know about the consultation?
A. Information will be disclosed on a limited basis after an NDA is signed, and no disclosure to related parties will occur before the final agreement. Strict confidentiality is maintained.
Related Columns
- Hospital/Medical Corporation Business Succession Complete Guide | Medical M&A Practices from Successor Shortages to Success Stories
- Clinic Sale/Transfer Complete Guide | Medical M&A Experts Explain Price Ranges, Procedures, and Precautions
- How to Proceed with Medical M&A/Hospital Succession | 6 Steps from Consultation to Closing Explained with Examples
- Complete Guide to Medical Corporation M&A Tax Schemes | Key Issues for Tax Accountants and CPAs
For consultations on OB/GYN Designated Medical Corporation conversion, contact M&A Medical.
Strict Confidentiality – Free Initial Consultation – Success Fee Basis